{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_6989377_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"035-112-790-066-633","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8892,"type":"PATENT","title":"University of Wisconsin Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":15082,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8214,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners = \"Wisconsin University\" , \"University of Wisconsin\", \"Wisconsin Univ\", \" Univ Wisconsin\" , \"Wisco* Alum* Res* Found*\".
Select more for logical variants
Add to collection
Search Applicants and Owners = \"Wisconsin University\" , \"University of Wisconsin\", \"Wisconsin Univ\", \" Univ Wisconsin\" , \"Wisco* Alum* Res* Found*\".
Select more for logical variants
Add to collection
administering a therapeutically effective amount of a biologically active vitamin D compound selected from 1,25-dihydroxyvitamin D3 or 1α-hvdroxyvitamin D3, and a therapeutically effective amount of interleukin-10 to a subject with symptoms of a vitamin D responsive disease, wherein said vitamin D responsive disease is selected from the group consisting of osteoporosis, renal osteodystrophy, psoriasis, multiple sclerosis, arthritis, ulcerative colitis, and Crohn's disease."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said administration does not cause severe or moderate hypercalcemia."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, further comprising determining if said subject is an IL-10 deficient subject."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said at least one vitamin D responsive disease is selected from the group consisting of osteoporosis, renal osteodystrophy, psoriasis, multiple sclerosis, and arthritis."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said vitamin D responsive disease is ulcerative colitis or Crohn's disease."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said interleukin-10 is human."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said interleukin-10 is recombinant."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said biologically active vitamin D compound is 1,25-dihydroxyvitamin D3."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said biologically active vitamin D compound is 1α-hydroxyvitamin D3."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said administering is via a transdermal patch."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said therapeutically effective amount of said biologically active vitamin D compound comprises a daily dose of at least 5 μg per day."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein said therapeutically effective amount of said interleukin-10 comprises a daily dose of approximately 4-6 μg per kilogram of said subject per day."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["A composition comprising a first amount of a biologically active vitamin D compound selected from 1,25-dihydroxyvitamin D3 or 1α-hydroxyvitamin D3, and a second amount of interleukin-10, wherein said first amount is between 0.01 μg and 50 μg, and wherein said second amount is between 25 μg and 500 μg."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said first amount is between 0.1 μg and 25 μg."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said second amount is between 175 μg-400 μg."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said second amount is between 250 μg-350 μg."],"number":16,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said interleukin-10 is human."],"number":17,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said interleukin-10 is recombinant."],"number":18,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said biologically active vitamin D compound is 1,25-dihydroxyvitamin D3."],"number":19,"annotation":false,"claim":true,"title":false},{"lines":["The composition of claim 13, wherein said biologically active vitamin D compound is 1α-hydroxyvitamin D3."],"number":20,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}